08-31-2023
INR/share | |
Price | 830.00 |
Dividend | 7.47 |
Earnings | 39.90 |
Cash-flow | 41.50 |
Book value | 461.11 |
Equity | 438.46 |
Aurobindo Pharmaceutical is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Aurobindo Pharmaceutical is a company from India, and his stocks are publicly traded.
Aurobindo Pharmaceutical stock dividend
Aurobindo Pharmaceutical paid a total dividend of 4,377 million INR last year, for a market value of 486,380 millions (Market Cap 220,015 millions). Aurobindo Pharmaceutical dividend per share is 7.47 INR, and his stock market price 830.00 INR.
According to the chart below, where dividend yield is displayed, Aurobindo Pharmaceutical has a dividend yield of 0.90%, lower than the amount offered by both the market average and companies from India. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...
In addition, you should compare Aurobindo Pharmaceutical stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high India dividend stocks list.
Aurobindo Pharmaceutical Dividend Payout
About the ability of Aurobindo Pharmaceutical to maintain his current dividend of INR 7.47 per share, an amount that accounts for 0.90%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Aurobindo Pharmaceutical payout on ernings is currently 18.72%, which is lower than the market average and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures lead us to believe that there is confidence that Aurobindo Pharmaceuticalcan maintain his current dividend.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Aurobindo Pharmaceutical is INR 41.50 per share, which is higher than the dividend per share paid by the company of INR 7.47, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Aurobindo Pharmaceutical, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Aurobindo Pharmaceut Dividend History
Below you will find a table with the historical evolution of Aurobindo Pharmaceut's dividend stock, both in percentage and in INR, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | INR | Paypout | Shares* |
Present | 0.90% | 7.47 | 18.72% | 586 |
2022 | 2.05% | 8.99 | 17.64% | 586 |
2021 | 0.61% | 4.48 | 4.70% | 586 |
2020 | 0.46% | 4.24 | 8.10% | 586 |
2019 | 0.55% | 2.51 | 5.99% | 586 |
2018 | 0.31% | 2.27 | 5.30% | 586 |
2017 | 0.40% | 2.75 | 6.84% | 586 |
2016 | 0.36% | 2.67 | 7.64% | 582 |
2015 | 0.32% | 2.59 | 9.40% | 582 |
*In millions
Then you can see the evolution of Aurobindo Pharmaceutical dividend stock, and compare it with the average of India stocks and that of the Pharmaceuticals and Biotechnology stocks.
Aurobindo Pharmaceutical Stock performance
Finally, last moth Aurobindo Pharmaceutical showed a return of 0.90% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 52.20% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.